Immunome Inc.

IMNMReported to SECin USCIK 0001472012Filings at SEC EDGAR

No score on this page, by design. Everything here is a fact from a public U.S. register: insider filings at the SEC (Form 4), lobbying filings under the Lobbying Disclosure Act, trades reported by members of Congress under the STOCK Act, and fund holdings in 13F filings. Our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 5 rows. Those are the 5 most recent Form 4 lines at this company, out of 41. Reading the whole list, and the full version of each filer's page, is part of the subscription. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

The most recent filings

Most recent filing first: every line of every Form 4 at this company that passed our review, the same lines as on the register. Reported is the day the filing reached the SEC, usually within two business days of the trade. Amounts are in U.S. dollars, as the form states them.

5 of 41
Form 4 lines at Immunome Inc., most recent filing first
Filed byTypeValueReportedFiled byValueTypeSharesReported
Higgins JackChief Scientific OfficerOption exercisenothing paid18,000 sharesSep 15, 2026Higgins JackChief Scientific Officernothing paidExercise · Sep 15Option exercise18,000Sep 15, 2026
Higgins JackChief Scientific OfficerGiftnothing paid8,800 sharesSep 15, 2026Higgins JackChief Scientific Officernothing paidGift · Sep 15Gift8,800Sep 15, 2026
Higgins JackChief Scientific OfficerOpen-market sell$334,22413,200 sharesSep 15, 2026Higgins JackChief Scientific Officer$334,224Sell · Sep 15Open-market sell13,200Sep 15, 2026
Higgins JackChief Scientific OfficerOption exercise$24,30018,000 sharesSep 15, 2026Higgins JackChief Scientific Officer$24,300Exercise · Sep 15Option exercise18,000Sep 15, 2026
Barchas Isaac—Open-market sell$301,05811,048 sharesAug 12, 2026Barchas Isaac$301,058Sell · Aug 12Open-market sell11,048Aug 12, 2026